All terms in HP_DEV

Label Id Description
embryonic facial prominence UBERON_0012314 [One of five swellings formed during the development of the face.]
Normochromic microcytic anemia HP_0004856 [A type of anemia characterized by an normal concentration of hemoglobin in the erythrocytes and lower than normal size of the erythrocytes.]
Microcytic anemia HP_0001935 [A kind of anemia in which the volume of the red blood cells is reduced.]
Hyperchromic macrocytic anemia HP_0004857 [A type of anemia characterized by abnormally large erythrocytes with abnormally high amounts of hemoglobin.]
Macrocytic anemia HP_0001972 [A type of anemia characterized by increased size of erythrocytes with increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).]
Intermittent thrombocytopenia HP_0004854 [Reduced platelet count that occurs sporadically, i.e., it comes and goes.]
Thrombocytopenia HP_0001873 [A reduction in the number of circulating thrombocytes.]
bilirubin(2-) CHEBI_57977 [A dicarboxylic acid dianion obtained by deprotonation of the two carboxy groups of bilirubin; major species at pH 7.3.]
Reduced protein S activity HP_0004855 [An abnormality of coagulation related to a decreased concentration of vitamin K-dependent protein S. Protein S is a cofactor of protein C.]
Abnormality of the protein C anticoagulant pathway HP_0030780 [An anomaly of the protein C anticoagulant pathway, which serves as a major system for controlling thrombosis, limiting inflammatory responses, and potentially decreasing endothelial cell apoptosis in response to inflammatory cytokines and ischemia. A natural anticoagulant system denoted the protein C pathway exerts its anticoagulant effect by regulating the activity of FVIIIa and FVa. The vitamin K-dependent protein C is the key component of the pathway. Activated protein C (APC) cleaves and inhibits coagulation cofactors FVIIIa and FVa, which result in downregulation of the activity of the coagulation system. The endothelial protein C receptor stimulates the T-TM-mediated activation of protein C on the endothelial cell surface. The two cofactors, protein S and the intact form of FV, enhance the anticoagulant activity of APC.]
Reduced leukocyte alkaline phosphatase HP_0004852 [Decreased alkaline phosphatase measured within leukocytes.]
Low alkaline phosphatase HP_0003282 [Abnormally reduced serum levels of alkaline phosphatase.]
Recurrent deep vein thrombosis HP_0004850 [Repeated episodes of the formation of a blot clot in a deep vein.]
Deep venous thrombosis HP_0002625 [Formation of a blot clot in a deep vein. The clot often blocks blood flow, causing swelling and pain. The deep veins of the leg are most often affected.]
Folate-responsive megaloblastic anemia HP_0004851 [A type of megaloblastic anemia (i.e., anemia characterized by the presence of erythroblasts that are larger than normal) that improves upon the administration of folate.]
Megaloblastic anemia HP_0001889 [Anemia characterized by the presence of erythroblasts that are larger than normal (megaloblasts).]
phosphate(3-) CHEBI_18367 [A phosphate ion that is the conjugate base of hydrogenphosphate.]
phosphate ion CHEBI_35780 [A phosphorus oxoanion that is the conjugate base of phosphoric acid.]
type 2 immune response GO_0042092 [An immune response which is associated with resistance to extracellular organisms such as helminths and pathological conditions such as allergy, which is orchestrated by the production of particular cytokines, most notably IL-4, IL-5, IL-10, and IL-13, by any of a variety of cell types including T-helper 2 cells, eosinophils, basophils, mast cells, and nuocytes, resulting in enhanced production of certain antibody isotypes and other effects.]
immune response GO_0006955 [Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.]